PureTech Health plc, a science-driven healthcare company, focuses on developing technologies that seek to address significant healthcare markets. The company, through its subsidiaries and operating companies, engages in developing microbiome immune system drug-discovery platform and drug candidates for the treatment of immune-mediated diseases; and products that seek to induce weight loss and potentially enhance glycaemic control through an orally administered capsule. It is also developing technology and products for the screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for ps...
501 Boylston Street
Boston, MA 02116
Founded in 2015
PureTech Health plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015
Aug 25 15
PureTech Health plc reported unaudited consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported revenue of $10,989,000 against $1,140,000 a year ago. The increase in revenue is primarily attributable to a $10.0 million non-refundable payment Vedanta Biosciences received as part of its collaboration with Janssen Biotech to develop and commercialise VE202, a microbiome product candidate. Operating loss was $11,606,000 against $4,918,000 a year ago. Loss before taxes was $15,475,000 against $32,837,000 a year ago. The $17.3 million decrease in the first half of 2015 results from a $6.7 million increase in operating loss offset by a decline of $24 million in net finance costs. Loss for the period was $17,234,000 against $32,837,000 a year ago. Net cash outflow from operating activities was $2,054,000 against $3,325,000 a year ago. Basic and diluted loss per share was $0.06 against $0.26 a year ago. Purchase of property and equipment was $2,247,000 against $67,000 a year ago. Loss attributable to owners of the company was $9,327,000 against $16,398,000 a year ago.
PureTech Health plc to Report First Half, 2015 Results on Aug 25, 2015
Aug 19 15
PureTech Health plc announced that they will report first half, 2015 results on Aug 25, 2015
PureTech Names Marko Ahtisaari as CEO
Jul 15 15
PureTech announced that it has named a former Nokia executive as its first CEO. Marko Ahtisaari, who served as head of design for the Nokia a few years back, was named to head the startup less than a year after it was launched. Ahtisaari, 45, left his position at Nokia in 2013 after four years, a job he came into after Nokia bought the company he previously co-founded and led, a social networking service called Dopplr. Now, he is a Director's Fellow at the MIT Media Lab.